Biogen's tau-targeting Alzheimer's drug shows cognitive slowing at lowest dose but misses primary goal due to inverted dose response; mixed results raise hope and questions for tau therapies.

Overdose deaths in the US fall for third year, a milestone but experts warn of lingering risks from fentanyl and new synthetics. Cautious optimism paired with urgent need for sustained funding.

Takeda plans 4,500 job cuts by 2026; Biogen reports mixed Phase 2 data for tau-targeting Alzheimer's drug diranersen.

Major digital health firms like Omada and Noom are absent from Medicare's chronic care experiment, raising concerns about the program's effectiveness and patient access.

CREATE Medicines raises $122M for in vivo CAR-T in autoimmune diseases; Trump admin searches for new FDA commissioner, creating regulatory uncertainty.

Discover why consumer stocks are dirt cheap near market highs due to tariffs and gas prices. Learn how to find value with $1,000, spot bargain criteria, and key sub-sectors to watch.

Carlson Investments bought 213,025 Fastly shares in Q1 2026 worth $3.5M. This article analyzes the investment, Fastly's edge cloud business, and whether the stock is a buy.

Explore why the traditional 4% retirement withdrawal rule may be too risky during high inflation and learn flexible alternatives to protect your savings.

Comparing Palantir and BigBear.ai quarterly revenue trends: Palantir's 53% net margin and defense deal contrast with BigBear.ai's slower growth and consulting model. Key insights for investors.

Analyzes Solana's price drop, FTX liquidation, tech strengths, risks, and 2026 investment outlook—buy, sell, or hold.

Deepfake porn victimizes not just the face but the body's owner—often adult performers—whose likeness is stolen and used for AI training. This listicle reveals six shocking facts: the emotional shock of body repurposing, AI training abuse, ignored victims, nudify apps' proliferation, immense psychological toll, and lagging legal protections.

Explore 7 key developments from the Tesla Semi's production launch, environmental impact, specs, delays, and a major order that signal a turning point for electric trucking.

Understand the urgent shift from 'capability now, control later' to full AI and data sovereignty. Learn why 70% of executives demand sovereign platforms, how national policy is evolving, and how to reclaim control.

Learn 7 essential steps for data readiness in financial services agentic AI, from trusted foundations to auditability and real-time processing.

Kubernetes v1.36 alpha introduces server-side sharded list and watch, drastically reducing API server load by filtering events at source instead of discarding after receipt.

Kubernetes v1.36 graduates DRA's Prioritized List to stable, plus beta features for extended resources, device tainting, and partitioning, enabling flexible hardware management.

Kubernetes v1.36 GA volume group snapshots provide crash-consistent multi-volume backups for production, eliminating application quiescence.

Kubernetes v1.36 GA's PSI metrics provide production-grade stall-time detection for CPU, memory, I/O with negligible overhead, backed by SIG Node testing at 80+ pods per node.

Kubernetes v1.36 introduces PodGroup API, decoupling scheduling state from templates, enabling atomic processing, topology-aware scheduling, and DRA for AI/ML workloads.

Embark Studios shifts Arc Raiders to biannual major updates; first expansion 'Frozen Trail' features the largest map yet, new enemies, and environmental challenges.